Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Research & Development (2016)

Microbot Medical's Research & Development history spans 7 years, with the latest figure at $3.7 million for Q2 2016.

  • For the quarter ending Q2 2016, Research & Development fell 48.97% year-over-year to $3.7 million, compared with a TTM value of $14.8 million through Sep 2016, down 47.06%, and an annual FY2020 reading of $3.4 million, up 11.42% over the prior year.
  • Research & Development for Q2 2016 was $3.7 million at Microbot Medical, down from $5.2 million in the prior quarter.
  • The five-year high for Research & Development was $7.7 million in Q3 2015, with the low at $3.5 million in Q3 2012.
  • Average Research & Development over 5 years is $5.1 million, with a median of $4.8 million recorded in 2013.
  • Year-over-year, Research & Development skyrocketed 75.57% in 2015 and then tumbled 48.97% in 2016.
  • Tracing MBOT's Research & Development over 5 years: stood at $3.5 million in 2012, then skyrocketed by 36.94% to $4.8 million in 2013, then soared by 37.82% to $6.6 million in 2014, then decreased by 11.71% to $5.9 million in 2015, then crashed by 36.96% to $3.7 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Research & Development are $3.7 million (Q2 2016), $5.2 million (Q1 2016), and $5.9 million (Q4 2015).